INTERPACE BIOSCIENCES, INC. Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period
New shares the company issued (share-based compensation, option exercises, employee stock purchase plans, new issues, acquisitions), as filed in its 10-Q and 10-K XBRL statement of shareholders' equity. This is the dilution side; Issuer Repurchases is the other side.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2022 was 0.00 shares, a 100.00% decline from fiscal 2021.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2021 was 13.04K shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2020 was 0.00 shares.
- INTERPACE BIOSCIENCES, INC. share-based compensation arrangement by share-based payment award, options, exercises in period for fiscal 2016 was 0.00 shares.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Options, Exercises in Period 12 month |
|---|---|---|
| 2022-12-31 | 0.00 shares 10-K · filed 2023-03-27 | |
| 2021-12-31 | 13.04K shares 10-K · filed 2023-03-27 | |
| 2020-12-31 | 0.00 shares 10-K · filed 2022-03-31 | |
| 2016-12-31 | 0.00 shares 10-K · filed 2017-03-31 | |
| 2015-12-31 | 0.00 shares 10-K · filed 2016-03-30 | |
| 2014-12-31 | 0.00 shares 10-K · filed 2015-03-05 | |
| 2013-12-31 | -13.18K shares 10-K · filed 2014-03-06 | |
| 2012-12-31 | -38.17K shares 10-K · filed 2013-03-15 |